Pfizer Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2016 | DOJ_CIVIL | $784,600,000 |
Merck & Company | Merck | pharmaceuticals | False Claims Act and related | 2008 | DOJ_CIVIL | $650,000,000 |
Mylan Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2017 | DOJ_CIVIL | $465,000,000 |
Mylan Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $465,000,000 |
Indivior Inc. | Indivior PLC | pharmaceuticals | price-fixing or anti-competitive practices | 2024 | private lawsuit-federal | $385,000,000 |
Wyeth Pharmaceuticals, Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $371,351,180 |
McKesson Corp. | McKesson | wholesalers | price-fixing or anti-competitive practices | 2009 | private lawsuit-federal | $350,000,000 |
Schering-Plough Corporation | Merck | pharmaceuticals | kickbacks and bribery | 2004 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $292,969,482 |
Merck | Merck | pharmaceuticals | False Claims Act and related | 2008 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $290,000,000 |
Dey Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
Roxane Laboratories Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | DOJ_ANTITRUST | $275,000,000 |
Mallinckrodt ARD LLC | Mallinckrodt | pharmaceuticals | False Claims Act and related | 2022 | DOJ_CIVIL | $260,000,000 |
Bayer Corporation | Bayer | chemicals | False Claims Act and related | 2003 | DOJ_CIVIL | $251,000,000 |
Centene Corporation | Centene | healthcare services | False Claims Act and related | 2023 | CA-AG | $215,000,000 |
Taro Pharmaceuticals USA, Inc. | Sun Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2021 | DOJ_CIVIL | $213,200,000 |
Sandoz Inc. | Sandoz Group | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | DOJ_ANTITRUST | $195,000,000 |
McKesson Corporation | McKesson | wholesalers | False Claims Act and related | 2012 | DOJ_CIVIL | $190,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2008 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $187,000,000 |
Sandoz Inc. | Sandoz Group | pharmaceuticals | False Claims Act and related | 2021 | DOJ_CIVIL | $185,000,000 |
Teva Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | MULTI-AG | $169,000,000 |
Par Pharmaceuticals, Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2011 | MULTI-AG | $154,000,000 |
McKesson Corporation | McKesson | wholesalers | False Claims Act and related | 2012 | MULTI-AG | $151,000,000 |
GlaxoSmithKline | GSK plc | pharmaceuticals | False Claims Act and related | 2005 | DOJ_CIVIL | $150,000,000 |
Sandoz Inc. | Sandoz Group | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $150,000,000 |
TAP Pharmaceutical Products | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $150,000,000 |
Abbott Laboratories Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $126,500,000 |
King Pharmaceuticals | Pfizer | pharmaceuticals | False Claims Act and related | 2005 | DOJ_CIVIL | $124,000,000 |
King Pharmaceuticals | Pfizer | pharmaceuticals | False Claims Act and related | 2006 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $124,000,000 |
Actavis Mid-Atlantic LLC | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $118,614,000 |
Mylan Pharmaceuticals and UDL Laboratories | Viatris | pharmaceuticals | False Claims Act and related | 2009 | DOJ_CIVIL | $118,000,000 |
Mylan Pharmaceuticals, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $118,000,000 |
Bayer AG | Bayer | chemicals | False Claims Act and related | 2003 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $108,000,000 |
Mylan Laboratories et al. | Viatris | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $108,000,000 |
Indivior Inc. | Indivior PLC | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | MULTI-AG | $102,500,000 |
Aventis Pharmaceutical Inc. | Sanofi | pharmaceuticals | False Claims Act and related | 2009 | DOJ_CIVIL | $95,500,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $90,000,000 |
Centene Corp. | Centene | healthcare services | False Claims Act and related | 2021 | OH-AG | $88,300,000 |
McKesson Corp. | McKesson | wholesalers | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $82,000,000 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $79,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2021 | USAO | $75,000,000 |
Bristol Myers Squibb Co. | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2021 | MULTI-AG | $75,000,000 |
GlaxoSmithKline | GSK plc | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $75,000,000 |
GlaxoSmithKline | GSK plc | pharmaceuticals | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $70,000,000 |
Watson Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | MULTI-AG | $70,000,000 |
GlaxoSmithKline PLC | GSK plc | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $70,000,000 |
Taro Pharmaceutical USA Inc. | Sun Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $67,643,000 |
Mylan Inc. | Viatris | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $65,000,000 |
Lupin Pharmaceuticals, Inc. | Lupin Limited | pharmaceuticals | False Claims Act and related | 2019 | TX-AG | $63,000,000 |
Johnson & Johnson Vision Care, Inc. | Johnson & Johnson | pharmaceuticals | price-fixing or anti-competitive practices | 2001 | MULTI-AG | $60,000,000 |
Mylan Inc. | Viatris | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $57,000,000 |
Centene Corp. | Centene | healthcare services | False Claims Act and related | 2021 | IL-AG | $56,717,652 |
Centene Corp. | Centene | healthcare services | False Claims Act and related | 2021 | MS-AG | $55,500,000 |
Schering-Plough Corporation | Merck | pharmaceuticals | price-fixing or anti-competitive practices | 2009 | private lawsuit-federal | $55,000,000 |
GlaxoSmithKline LLC | GSK plc | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $54,653,931 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2004 | private lawsuit-federal | $50,000,000 |
Pfizer Inc. | Pfizer | pharmaceuticals | price-fixing or anti-competitive practices | 2024 | private lawsuit-federal | $50,000,000 |
Johnson & Johnson | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $49,505,368 |
Omnicare Inc. | CVS Health | retailing | False Claims Act and related | 2006 | USAO | $49,500,000 |
Pfizer Corporation | Pfizer | pharmaceuticals | False Claims Act and related | 2002 | DOJ_CIVIL | $49,000,000 |
Apotex Corporation | Apotex Corp. | pharmaceuticals | False Claims Act and related | 2021 | DOJ_CIVIL | $49,000,000 |
AstraZeneca LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2015 | DOJ_CIVIL | $46,500,000 |
AstraZeneca LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $46,500,000 |
Pfizer Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $41,047,101 |
Aventis Pharmaceutical Inc. | Sanofi | pharmaceuticals | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,000,000 |
Vyera Pharmaceuticals, LLC and Phoenixus AG | | | price-fixing or anti-competitive practices | 2021 | MULTI-AG | $40,000,000 |
McKesson Corporation | McKesson | wholesalers | False Claims Act and related | 2013 | VA-AG | $37,000,000 |
Watson, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2018 | MS-AG | $33,408,547 |
Schering-Plough | Merck | pharmaceuticals | False Claims Act and related | 2008 | MO-AG | $31,000,000 |
Sandoz, Inc. | Sandoz Group | pharmaceuticals | False Claims Act and related | 2011 | MS-AG | $30,110,618 |
Mylan N.V. | Viatris | pharmaceuticals | investor protection violation | 2019 | SEC | $30,000,000 |
Glenmark Pharmaceuticals Inc., USA | Glenmark Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | DOJ_ANTITRUST | $30,000,000 |
Baxter Healthcare Corp. | Baxter International | medical equipment and supplies | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $29,750,000 |
Pharmacia Corporation | Pfizer | pharmaceuticals | False Claims Act and related | 2013 | WI-AG | $29,453,247 |
Actavis Mid-Atlantic, LLC and Actavis Elizabeth, LLC | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | TX-AG | $29,230,000 |
Abbott Laboratories Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2008 | TX-AG | $28,000,000 |
Merck Sharp & Dohme Corp | Merck | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $28,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2010 | PA-AG | $27,600,000 |
Schering-Plough Corp. | Merck | pharmaceuticals | False Claims Act and related | 2004 | TX-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $27,000,000 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $27,000,000 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2001 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $25,516,440 |